Join the premier forum for Hatch-Waxman litigators and pharmaceutical patent practitioners.

Widely recognized as the industry gold standard, this event unites leaders from brand-name and generic drug companies, alongside federal judges, the U.S. PTO’s PTAB, the FTC, and the FDA, to tackle the critical legal, regulatory, and business issues shaping pharmaceutical patent litigation. Focusing on pre-suit strategies, case filings, final adjudications, and everything in between, this conference provides unparalleled insights and actionable takeaways for navigating the complex and high-stakes world of Paragraph IV disputes. Join us to stay at the forefront of legal developments and connect with top professionals in this dynamic and evolving field.